1986
DOI: 10.1007/bf00173505
|View full text |Cite
|
Sign up to set email alerts
|

Role of metabolism in effects of diflubenzuron on growth of B16 melanomas in mice

Abstract: The insect growth regulator diflubenzuron (DFB), which also inhibits growth of experimental tumors in mice, was studied to determine the influence of in vivo microsomal metabolism on its antitumor activity. DFB inhibits chitin synthesis and growth of imaginal epidermis in insects and suppresses melanogenesis and uptake of nucleosides in mouse melanoma cells, but the means of cell growth regulation and the role of metabolism of DFB in such regulation have not been established. Five daily injections of DFB (tota… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1993
1993
2016
2016

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…These observations help to explain why the diflubenzuron analogue ( 12 ) demonstrates such remarkable activity. Diflubenzuron ( 11 ) has two known modes of degradation, which promote resistance in arthropods: 1) acyl imide bond cleavage and 2) metabolic hydroxylation of the aniline ring followed by conjugation to sugars and excretion; presumably, at least the latter pathway is significantly diminished by cubane incorporation. Finally, to determine whether cubane‐for‐benzene replacement would promote alternative drug metabolism pathways, a phase I and II metabolic analysis of both leteprinim ( 5 ) and its cubane analogue ( 6 ) was undertaken.…”
Section: Figurementioning
confidence: 99%
“…These observations help to explain why the diflubenzuron analogue ( 12 ) demonstrates such remarkable activity. Diflubenzuron ( 11 ) has two known modes of degradation, which promote resistance in arthropods: 1) acyl imide bond cleavage and 2) metabolic hydroxylation of the aniline ring followed by conjugation to sugars and excretion; presumably, at least the latter pathway is significantly diminished by cubane incorporation. Finally, to determine whether cubane‐for‐benzene replacement would promote alternative drug metabolism pathways, a phase I and II metabolic analysis of both leteprinim ( 5 ) and its cubane analogue ( 6 ) was undertaken.…”
Section: Figurementioning
confidence: 99%